Renal cell carcinoma vaccine (FBM Pharma)

肾细胞癌疫苗

Report date: 2023/09/18 14:05:37

Base Information

Drug NameRenal cell carcinoma vaccine (FBM Pharma)
Drug Alias NameRenal cell cancer vaccine (FBM Pharma)Renal cell cancer vaccine (LipoNova)Renal cell cancer vaccine (Vaccentis)RenialeVCC-001
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsCarcinoma, Renal Cell
Approved Indications in ChinaN/A
Original Approved Country/TerritoryAustria
Original Approved Date2014/02/01
Country/TerritoryAustria
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesFbm-Pharma
China Registration ClassN/A

Develop Information

Active CompaniesFbm-Pharma
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeJ07X
Related LinksN/A